W

Whanin Pharm Co Ltd
KRX:016580

Watchlist Manager
Whanin Pharm Co Ltd
KRX:016580
Watchlist
Price: 10 700 KRW -0.19%
Market Cap: ₩163.4B

Net Margin

5.9%
Current
Declining
by 4.5%
vs 3-y average of 10.5%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
5.9%
=
Net Income
₩15.2B
/
Revenue
₩256.3B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
5.9%
=
Net Income
₩15.2B
/
Revenue
₩256.3B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Whanin Pharm Co Ltd
KRX:016580
174.1B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
FR
Sanofi SA
PAR:SAN
93.8B EUR
Loading...

Market Distribution

Higher than 71% of companies in Korea
Percentile
71th
Based on 2 632 companies
71th percentile
5.9%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Whanin Pharm Co Ltd
Glance View

Market Cap
163.4B KRW
Industry
Pharmaceuticals

Whan In Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical supplies. The company is headquartered in Seoul, Seoul. is a Korea-based company specialized in the manufacturing of pharmaceutical products. The Company’s products consist of antidepressants, antipsychotics, anxiolytics, hypnotics, antiepileptics, attention-deficit/hyperactivity disorder (ADHD) agents, nootropics, antiparkinson drugs, anti-dementia drugs, gastrointestinal drugs, cardiovascular drugs, immunostimulating agents, antibiotics, multi-vitamins, respiratory drugs, dermatologic drugs, antivirals, anti-diabetic agents and others. The firm also involves in the real estate rental business.

Intrinsic Value
6 983.85 KRW
Overvaluation 35%
Intrinsic Value
Price
W
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
5.9%
=
Net Income
₩15.2B
/
Revenue
₩256.3B
What is Whanin Pharm Co Ltd's current Net Margin?

The current Net Margin for Whanin Pharm Co Ltd is 5.9%, which is below its 3-year median of 10.5%.

How has Net Margin changed over time?

Over the last 3 years, Whanin Pharm Co Ltd’s Net Margin has decreased from 11.7% to 5.9%. During this period, it reached a low of 5.9% on Oct 30, 2025 and a high of 13.4% on Mar 31, 2024.

Back to Top